351 filings
8-K
MYMD
MyMD Pharmaceuticals Inc
18 Apr 24
Departure of Directors or Certain Officers
4:30pm
8-K
MYMD
MyMD Pharmaceuticals Inc
8 Apr 24
Entry into a Material Definitive Agreement
4:49pm
10-K
2023 FY
MYMD
MyMD Pharmaceuticals Inc
Annual report
1 Apr 24
5:29pm
8-K/A
MYMD
MyMD Pharmaceuticals Inc
26 Mar 24
Amendments to Articles of Incorporation or Bylaws
4:30pm
8-K
MYMD
MyMD Pharmaceuticals Inc
7 Mar 24
Entry into a Material Definitive Agreement
4:30pm
8-K
fqri76ff
5 Mar 24
Regulation FD Disclosure
11:00am
8-K
py074
13 Feb 24
MyMD Pharmaceuticals Announces Reverse Stock Split to Maintain Nasdaq Listing
4:57pm
8-K
b0hekd 4eh21khz1d58
6 Dec 23
Regulation FD Disclosure
9:15am
8-K
dnw86pgu74s0vui
19 Oct 23
MyMD Announces Preclinical Study Results Showing Novel Cannabidiol Analog, Supera-CBD™, Reduced
9:00am
8-K
qym1qz2riwh yh77
13 Oct 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:00pm
8-K
9nblahk9to6pzj95l
4 Oct 23
MyMD Pharmaceuticals to Present Updated Statistically Significant Phase 2 Data for MYMD-1, Potential TNF-α Market Disrupter, at BioFuture 2023
4:30pm
8-K
sljj2nreseopaqfyiq83
8 Sep 23
Departure of Directors or Certain Officers
5:24pm
8-K
emv3tx
14 Aug 23
Regulation FD Disclosure
8:30am
8-K
gbwezn2
3 Aug 23
MyMD Pharmaceuticals Phase 2 Trial Update
4:30pm
8-K
3ld4p5e33tp0
1 Aug 23
Submission of Matters to a Vote of Security Holders
4:30pm
8-K
lsglb5a9e2 am0k6w7es
31 Jul 23
MyMD Pharmaceuticals Reports Statistically Significant Positive Topline
9:00am
DEFA14A
q34nk7f5s6dpw3cf3vf7
21 Jul 23
Additional proxy soliciting materials
4:30pm
8-K
yy1thukz mp8z
14 Jul 23
Other Events
8:30am